Latest News and Press Releases

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation, a pioneering brain–computer interface (BCI) company, today announced a clinical research project with Beth Israel...

Victoria (BC), London & New York, Feb. 10, 2025 (GLOBE NEWSWIRE) -- British Columbia Investment Management Corporation (“BCI”), one of Canada’s largest institutional investors, today announced...

The raise brings Precision’s total funding to $155 million, solidifying its position as a leader in the brain–computer interface industry.Investors include General Equity Holdings, B Capital, Stanley...

ONWARD Medical Awarded Grant to Study Potential for ARC BCI Therapy to Restore Movement after Stroke

NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Researchers shared groundbreaking results today from a pilot study conducted in collaboration with Precision Neuroscience Corporation (Precision), a...

NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leader in developing brain–computer interface technology to restore function and autonomy for millions...

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Brain–computer interface company Precision Neuroscience Corporation (Precision) and a neurosurgery team from the Mount Sinai Health System now hold the...

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision) today announced that Dr. Brian Otis has joined the company as Chief Technology Officer. An expert in chip...

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision) today announced the launch of two new clinical study sites, at...

EINDHOVEN, the Netherlands, Feb. 29, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...